Lun‐Jie Yan

818 total citations
47 papers, 494 citations indexed

About

Lun‐Jie Yan is a scholar working on Cancer Research, Oncology and Epidemiology. According to data from OpenAlex, Lun‐Jie Yan has authored 47 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cancer Research, 17 papers in Oncology and 16 papers in Epidemiology. Recurrent topics in Lun‐Jie Yan's work include Liver Disease Diagnosis and Treatment (13 papers), Hepatocellular Carcinoma Treatment and Prognosis (12 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Lun‐Jie Yan is often cited by papers focused on Liver Disease Diagnosis and Treatment (13 papers), Hepatocellular Carcinoma Treatment and Prognosis (12 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Lun‐Jie Yan collaborates with scholars based in China, Sweden and Japan. Lun‐Jie Yan's co-authors include Zhao‐Ru Dong, Tao Li, Zi‐Niu Ding, Yu‐Chuan Yan, Zhiqiang Chen, Jian‐Guo Hong, Dongxu Wang, Hui Liu, Chuncheng Yang and Yafei Yang and has published in prestigious journals such as Hepatology, Cancer Research and Frontiers in Immunology.

In The Last Decade

Lun‐Jie Yan

43 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lun‐Jie Yan China	12	215	127	121	102	99	47	494
Zhiqiang Chen China	11	199 0.9×	110 0.9×	106 0.9×	109 1.1×	87 0.9×	45	505
Zi‐Niu Ding China	11	179 0.8×	110 0.9×	112 0.9×	72 0.7×	75 0.8×	45	391
Rumi Matono Japan	14	206 1.0×	192 1.5×	114 0.9×	81 0.8×	78 0.8×	24	591
Kouki Hoshino Japan	12	222 1.0×	60 0.5×	103 0.9×	94 0.9×	45 0.5×	56	421
Rongqiang Liu China	13	196 0.9×	42 0.3×	106 0.9×	109 1.1×	96 1.0×	52	480
Chihao Zhang China	19	175 0.8×	115 0.9×	145 1.2×	182 1.8×	142 1.4×	45	610
Naohiro Hosomura Japan	14	305 1.4×	103 0.8×	111 0.9×	104 1.0×	79 0.8×	68	662
Takayoshi Kaida Japan	16	401 1.9×	127 1.0×	137 1.1×	159 1.6×	155 1.6×	44	761
Susie Chin South Korea	10	198 0.9×	57 0.4×	102 0.8×	149 1.5×	39 0.4×	33	564
Katsuki Miyazaki Japan	12	125 0.6×	50 0.4×	39 0.3×	126 1.2×	100 1.0×	35	414

Countries citing papers authored by Lun‐Jie Yan

Since Specialization

Citations

This map shows the geographic impact of Lun‐Jie Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lun‐Jie Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lun‐Jie Yan more than expected).

Fields of papers citing papers by Lun‐Jie Yan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lun‐Jie Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lun‐Jie Yan. The network helps show where Lun‐Jie Yan may publish in the future.

Co-authorship network of co-authors of Lun‐Jie Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Lun‐Jie Yan. A scholar is included among the top collaborators of Lun‐Jie Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lun‐Jie Yan. Lun‐Jie Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Hui, Lun‐Jie Yan, Zi‐Niu Ding, et al.. (2025). An umbrella review of the association between dietary factors and hepatocellular carcinoma risk. Food & Function. 16(10). 3879–3890.

Ding, Zi‐Niu, Lun‐Jie Yan, Dongxu Wang, et al.. (2025). Hypoxia-Induced Creatine Uptake Reprograms Metabolism to Antagonize PARP1-Mediated Cell Death and Facilitate Tumor Progression in Hepatocellular Carcinoma. Cancer Research. 85(19). 3671–3688.

Liu, Shijia, Xiao Zhang, Lun‐Jie Yan, et al.. (2025). Comparison of tenofovir versus entecavir for preventing hepatocellular carcinoma in chronic hepatitis B patients: an umbrella review and meta-analysis. Journal of Cancer Research and Clinical Oncology. 151(2). 77–77.

Wang, Dongxu, Hui Liu, Lun‐Jie Yan, et al.. (2024). Neoadjuvant immunotherapy based on PD-1/L1 inhibitors for gastrointestinal tumors: a review of the rationale and clinical advances. International Journal of Surgery. 110(6). 3707–3722. 3 indexed citations

Liu, Hui, Lun‐Jie Yan, Zi‐Niu Ding, et al.. (2024). Role of hepatitis B core‐related antigen in predicting the occurrence and recurrence of hepatocellular carcinoma in patients with chronic hepatitis B: A systemic review and meta‐analysis. Journal of Gastroenterology and Hepatology. 39(8). 1464–1475. 2 indexed citations

Tan, Siyu, Pan Guoqiang, Lun‐Jie Yan, et al.. (2024). DAP3 promotes mitochondrial activity and tumour progression in hepatocellular carcinoma by regulating MT-ND5 expression. Cell Death and Disease. 15(7). 540–540. 5 indexed citations

Han, Cheng‐Long, Bao‐Wen Tian, Chuncheng Yang, et al.. (2023). The association of fatty liver and risk of hepatocellular carcinoma in HBV or HCV infected individuals: a systematic review and meta-analysis. Expert Review of Gastroenterology & Hepatology. 17(2). 189–198. 3 indexed citations

Yan, Lun‐Jie, Yu‐Chuan Yan, Zi‐Niu Ding, et al.. (2023). Anthropometric indicators of adiposity and risk of primary liver cancer: A systematic review and dose–response meta-analysis. European Journal of Cancer. 185. 150–163. 8 indexed citations

Ma, Yunlong, Chuncheng Yang, Lun‐Jie Yan, et al.. (2023). A novel prognostic scoring model based on copper homeostasis and cuproptosis which indicates changes in tumor microenvironment and affects treatment response. Frontiers in Pharmacology. 14. 1101749–1101749. 7 indexed citations

10.

Chen, Xiong, Lun‐Jie Yan, Yu‐Chuan Yan, et al.. (2023). Construction of an anoikis‒related prognostic signature to predict immunotherapeutic response and prognosis in hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. 149(18). 16869–16884. 1 indexed citations

11.

Shi, Shuo, Lun‐Jie Yan, Zi‐Niu Ding, et al.. (2023). A model based on adipose and muscle-related indicators evaluated by CT images for predicting microvascular invasion in HCC patients. Biomarker Research. 11(1). 87–87. 11 indexed citations

12.

Long, Junyu, Dongxu Wang, Hui Liu, et al.. (2023). Comprehensive molecular analysis identifies RET alterations association with response of ICIs in multi-immunotherapy cohorts. International Immunopharmacology. 126. 111281–111281. 2 indexed citations

13.

Li, Guangzhen, Pan Guoqiang, Lun‐Jie Yan, et al.. (2023). MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway. Cancer Cell International. 23(1). 188–188. 11 indexed citations

14.

Hong, Jian‐Guo, Lun‐Jie Yan, Xian Li, et al.. (2022). Comments on validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease. World Journal of Gastroenterology. 28(6). 689–692. 1 indexed citations

15.

Han, Cheng‐Long, Zi‐Niu Ding, Zhao‐Ru Dong, et al.. (2022). The Predictive Potential of the Baseline C-Reactive Protein Levels for the Efficiency of Immune Checkpoint Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis. Frontiers in Immunology. 13. 827788–827788. 27 indexed citations

16.

Tian, Bao‐Wen, Lun‐Jie Yan, Zi‐Niu Ding, et al.. (2022). Evaluating liver function and the impact of immune checkpoint inhibitors in the prognosis of hepatocellular carcinoma patients: A systemic review and meta-analysis. International Immunopharmacology. 114. 109519–109519. 4 indexed citations

17.

Ding, Zi‐Niu, Zhao‐Ru Dong, Zhiqiang Chen, et al.. (2021). Effects of hypoxia‐inducible factor‐1α and hypoxia‐inducible factor‐2α overexpression on hepatocellular carcinoma survival: A systematic review with meta‐analysis. Journal of Gastroenterology and Hepatology. 36(6). 1487–1496. 6 indexed citations

18.

Xue, Jun-Shuai, Hui Liu, Zi‐Niu Ding, et al.. (2021). Prognostic value of soluble programmed cell death-1 (sPD-1) and soluble programmed cell death ligand-1 (sPD-L1) for hepatocellular carcinoma: a systematic review and meta-analysis. Cancer Immunology Immunotherapy. 71(7). 1633–1644. 11 indexed citations

19.

Yan, Lun‐Jie, Zi‐Niu Ding, Zhao‐Ru Dong, et al.. (2021). Sex and regional disparities in incidence of hepatocellular carcinoma in autoimmune hepatitis: a systematic review and meta-analysis. Hepatology International. 15(6). 1413–1420. 9 indexed citations

20.

Yan, Lun‐Jie, et al.. (2020). Lesion-aware convolutional neural network for chest radiograph classification. Clinical Radiology. 76(2). 155.e1–155.e14. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact